Tracey L Evans Selected Research

Melanoma (Melanoma, Malignant)

1/2017	Pretreatment neutrophil-to-lymphocyte ratio as a marker of outcomes in nivolumab-treated patients with advanced non-small-cell lung cancer.
8/2014	Phase I trial of hydroxychloroquine with dose-intense temozolomide in patients with advanced solid tumors and melanoma.
8/2014	Combined MTOR and autophagy inhibition: phase I trial of hydroxychloroquine and temsirolimus in patients with advanced solid tumors and melanoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Tracey L Evans Research Topics

Disease

19	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022 - 03/2002
13	Neoplasms (Cancer) 01/2022 - 01/2005
6	Lung Neoplasms (Lung Cancer) 01/2019 - 01/2004
5	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2019 - 08/2015
3	Pneumonia (Pneumonitis) 01/2022 - 05/2008
3	Disease Progression 01/2019 - 11/2012
3	Melanoma (Melanoma, Malignant) 01/2017 - 08/2014
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2022
1	Malignant Pleural Effusion 01/2018
1	Brachial Plexus Neuropathies (Erb's Palsy) 01/2013
1	Venous Thromboembolism 11/2012
1	Stroke (Strokes) 11/2012
1	Esophagitis 04/2012
1	Thymoma (Thymic Carcinoma) 08/2011
1	Thymus Neoplasms (Thymus Neoplasm) 01/2005

Drug/Important Bio-Agent (IBA)

4	Pemetrexed (MTA)FDA Link 01/2022 - 11/2012
4	PlatinumIBA 01/2022 - 01/2015
4	ErbB Receptors (EGF Receptor)IBA 10/2019 - 05/2008
3	Circulating Tumor DNAIBA 01/2019 - 12/2016
2	Nelfinavir (Viracept)FDA Link 10/2019 - 04/2012
2	HIV Protease InhibitorsIBA 10/2019 - 04/2012
2	Topotecan (Hycamtin)FDA LinkGeneric 12/2018 - 08/2015
2	cabazitaxel FDA Link 12/2018 - 08/2015
2	Biomarkers (Surrogate Marker)IBA 01/2017 - 01/2015
2	DNA (Deoxyribonucleic Acid)IBA 12/2016 - 05/2008
2	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 08/2014 - 08/2014
1	Gemcitabine FDA Link 01/2022
1	130-nm albumin-bound paclitaxelIBA 01/2022
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 10/2019
1	etirinotecan pegolIBA 01/2018
1	IpilimumabIBA 01/2017
1	Folic Acid (Vitamin M)FDA LinkGeneric 01/2017
1	NivolumabIBA 01/2017
1	taxaneIBA 08/2015
1	Taxoids (Taxanes)IBA 08/2015
1	Dinoprostone (PGE2)FDA Link 01/2015
1	apricoxibIBA 01/2015
1	Docetaxel (Taxotere)FDA Link 01/2015
1	Temozolomide (Temodar)FDA LinkGeneric 08/2014
1	temsirolimus FDA Link 08/2014
1	O,O-diisopropyl-S-benzylthiophosphate (IBP)IBA 01/2013
1	Bevacizumab (Avastin)FDA Link 11/2012
1	Carboplatin (JM8)FDA LinkGeneric 11/2012
1	Tyrosine Kinase InhibitorsIBA 05/2008
1	Gefitinib (Iressa)FDA Link 05/2008
1	Cisplatin (Platino)FDA LinkGeneric 01/2005

Therapy/Procedure

9	Therapeutics 01/2022 - 03/2002
9	Drug Therapy (Chemotherapy) 01/2022 - 01/2005
4	Radiotherapy 10/2019 - 01/2013
2	Adjuvant Chemotherapy 10/2019 - 01/2004
2	Chemoradiotherapy 10/2019 - 04/2012
2	Combination Drug Therapy (Combination Chemotherapy) 01/2012 - 01/2005
1	Palliative Care (Palliative Therapy) 11/2018
1	Cranial Irradiation 01/2018
1	Immunotherapy 01/2018
1	Induction Chemotherapy 01/2018
1	Proton Therapy 11/2017
1	Adjuvant Radiotherapy 08/2011